- Home
- DHR
as 07-26-2024 4:00pm EST
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
| Founded: | 1969 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 185.8B | IPO Year: | N/A |
| Target Price: | $275.36 | AVG Volume (30 days): | 3.4M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.62 | EPS Growth: | -34.04 |
| 52 Week Low/High: | $182.09 - $277.72 | Next Earning Date: | 07-23-2024 |
| Revenue: | $21,105,000,000 | Revenue Growth: | -8.50% |
| Revenue Growth (this year): | 0.94% | Revenue Growth (next year): | 8.36% |
Stock Insider Trading Activity of Danaher Corporation (DHR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Blair Rainer | DHR | President & CEO | May 16 '24 | Sell | $265.00 | 9,005 | $2,386,325.00 | 106,990 | SEC Form 4 |
| Blair Rainer | DHR | President & CEO | May 14 '24 | Sell | $255.00 | 19,085 | $4,866,675.00 | 115,995 | SEC Form 4 |
| McGrew Matthew | DHR | EVP & Chief Financial Officer | May 10 '24 | Sell | $253.08 | 21,203 | $5,365,953.47 | 29,407 | SEC Form 4 |
| McGrew Matthew | DHR | EVP & Chief Financial Officer | May 10 '24 | Sell | $253.19 | 9,243 | $2,340,236.09 | 29,407 | SEC Form 4 |
| McGrew Matthew | DHR | EVP & Chief Financial Officer | May 10 '24 | Sell | $252.95 | 15,931 | $4,029,666.80 | 29,407 | SEC Form 4 |
| Weidemanis Joakim | DHR | Executive Vice President | Apr 25 '24 | Sell | $250.46 | 22,433 | $5,618,569.18 | 90,412 | SEC Form 4 |
| Ellis Brian W | DHR | Senior Vice President - GC | Apr 24 '24 | Sell | $250.01 | 4,000 | $1,000,040.00 | 29,830 | SEC Form 4 |
| Blair Rainer | DHR | President & CEO | Apr 24 '24 | Sell | $250.00 | 9,005 | $2,251,250.00 | 115,995 | SEC Form 4 |
| Blair Rainer | DHR | President & CEO | Apr 24 '24 | Sell | $249.03 | 38,170 | $9,505,475.10 | 115,995 | SEC Form 4 |
| Raskas Daniel | DHR | SVP - Corporate Development | Feb 26 '24 | Sell | $252.00 | 23,757 | $5,986,764.00 | 38,102 | SEC Form 4 |
| LOHR WALTER G | DHR | Director | Feb 15 '24 | Sell | $251.15 | 3,289 | $826,032.35 | 14,129 | SEC Form 4 |
| Couchara Georgeann | DHR | SVP, Human Resources | Feb 13 '24 | Sell | $242.66 | 844 | $204,805.04 | 4,244 | SEC Form 4 |
| Couchara Georgeann | DHR | SVP, Human Resources | Feb 13 '24 | Sell | $242.68 | 1,778 | $431,485.04 | 4,244 | SEC Form 4 |
Latest Danaher Corporation News
DHR Breaking Stock News: Dive into DHR Ticker-Specific Updates for Smart Investing
Zacks
9 hours ago
HTHIY or DHR: Which Is the Better Value Stock Right Now?
PR Newswire
a day ago
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
Zacks
2 days ago
Company News for Jul 24, 2024
GuruFocus.com
3 days ago
Danaher Corp: An Exploration into Its Intrinsic Value
Argus Research
3 days ago
Analyst Report: Danaher Corp.
Argus Research
3 days ago
Market Digest: CMA, COF, DHR, IVZ
Thomson Reuters StreetEvents
3 days ago
Q2 2024 Danaher Corp Earnings Call
GuruFocus.com
3 days ago
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Compare DHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DHR Danaher Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.